Your browser doesn't support javascript.
loading
Erratum to "A first-in-class CDK4 inhibitor demonstrates in vitro, ex-vivo and in vivo efficacy against ovarian cancer" [Gynecologic Oncology 159 (2020) 827-838].
Bantie, Laychiluh; Tadesse, Solomon; Likisa, Jimma; Yu, Mingfeng; Noll, Benjamin; Heinemann, Gary; Lokman, Noor A; Ricciardelli, Carmela; Oehler, Martin K; Beck, Andrew; Pradhan, Rupal; Milne, Robert; Albrecht, Hugo; Wang, Shudong.
Afiliação
  • Bantie L; Drug Discovery and Development, Cancer Research Institute and Clinical and Health Sciences, University of South Australia, Australia.
  • Tadesse S; Drug Discovery and Development, Cancer Research Institute and Clinical and Health Sciences, University of South Australia, Australia.
  • Likisa J; Drug Discovery and Development, Cancer Research Institute and Clinical and Health Sciences, University of South Australia, Australia.
  • Yu M; Drug Discovery and Development, Cancer Research Institute and Clinical and Health Sciences, University of South Australia, Australia.
  • Noll B; Drug Discovery and Development, Cancer Research Institute and Clinical and Health Sciences, University of South Australia, Australia.
  • Heinemann G; Drug Discovery and Development, Cancer Research Institute and Clinical and Health Sciences, University of South Australia, Australia.
  • Lokman NA; Discipline of Obstetrics and Gynaecology, Adelaide Medical School, Robinson Research Institute, University of Adelaide, Australia.
  • Ricciardelli C; Discipline of Obstetrics and Gynaecology, Adelaide Medical School, Robinson Research Institute, University of Adelaide, Australia.
  • Oehler MK; Discipline of Obstetrics and Gynaecology, Adelaide Medical School, Robinson Research Institute, University of Adelaide, Australia; Department of Gynaecologic Oncology, Royal Adelaide Hospital, Adelaide, Australia.
  • Beck A; Clinical and Health Sciences, University of South Australia, Australia.
  • Pradhan R; Clinical and Health Sciences, University of South Australia, Australia.
  • Milne R; Drug Discovery and Development, Cancer Research Institute and Clinical and Health Sciences, University of South Australia, Australia.
  • Albrecht H; Drug Discovery and Development, Cancer Research Institute and Clinical and Health Sciences, University of South Australia, Australia.
  • Wang S; Drug Discovery and Development, Cancer Research Institute and Clinical and Health Sciences, University of South Australia, Australia. Electronic address: shudong.wang@unisa.edu.au.
Gynecol Oncol ; 163(1): 215, 2021 Oct.
Article em En | MEDLINE | ID: mdl-34340816
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article